Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
Not yet recruiting · NCT07595900 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis | Female Urogenital Diseases and Pregnancy Complications, Skin and Connective Tissue Diseases, Urogenital Diseases, breast disorder, granulomatous mastitis, mastitis, pregnancy disorder, puerperal disorder, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-05-19 | NCT07595900 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 285 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||